11:49 AM EST - Trillium Therapeutics Inc. : Has acquired all of the outstanding shares of privately-held Fluorinov Pharma Inc. The transaction combines Fluorinov's pipeline of oncology therapeutics and risk-reduced drug discovery engine, with Trillium's pool of innovative immuno-oncology therapies. Trillium Therapeutics Inc.
shares T.TR are trading down $0.72 at $12.00.
